When MnK inhibitors were applied to in vitro and in vivo models of melanoma, lymphoma, colon cancer, and lung cancer, blocking the phosphorylation of eIF4E was found to inhibit cell proliferation and metastasis [203]. The gene discussed is EIF4E; the disease is lung carcinoma.